Kawa Chiu

Rackspace MailGun Outlook Mobile Friendly Google Tag Manager WordPress.org Remote Render

biotechnology research precision oncology radiotherapeutics targeted cancer therapy antibody engineering precision medicine alpha-emitting radionuclide beta-emitting radionuclide radioisotope delivery cancer cell targeting rover platform therapeutic index optimization solid tumors clinical trials systemic toxicities myelosuppression mitigation phase 1 clinical trial dll3 targeting advanced antibody technology linker-chelator technology heavy chain antibodies high affinity antibodies antigen binding domain chelated radioisotope tumor penetration renal protection therapeutic radiation tumor cell destruction imaging isotopes oncology drug development biologics development collaborative drug discovery potent cell killing mechanisms clinical development guidance highly potent therapeutics solid tumor targeting pharmacokinetic properties innovative cancer treatments target engagement measurement dosimetry assessment antibody-based therapies next-generation therapies biopharmaceutical development cancer treatment alternatives high unmet medical need antibody-drug conjugates theranostic agents biopharmaceutical targeted alpha therapies cancer treatment innovative therapies small cell lung cancer large cell neuroendocrine carcinoma advanced cancer drug discovery fast track designation orphan drug designation oncology patient-centered care advanced radiopharmaceuticals therapeutic effect cancer patients healthcare professionals oncology networks novel therapies cancer research biotechnology cancer care patient advocacy therapeutic innovation personalized medicine health care health wellness & fitness hospital & health care